Recipharm M&A Summary
Recipharm has acquired 18 companies, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Recipharm’s largest acquisition to date was in 2016, when it acquired Mitim Srl for $77M. It’s largest disclosed sale occurred in 2020, when it sold Lusomedicamenta Sociedade Técnica Farmacêutica S.A. to Laboratorio Medinfar – Produtos Farmaceuticos S.A. for $29M. Recipharm has acquired in 2 different US states, and 9 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).
M&A Summary
-
M&A Total Activity19
- M&A Buy Activity18
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 9
- M&A Buy/Sell Connections 9
Unlimited Searches
